Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.53 |
| ▸ | MT-CO2 | P00403 | 3/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.49 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CA3 | P07451 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8895853 | 0.82 | PTGS2 (0.52) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 | |
| SCHEMBL8921742 | 0.82 | PTGS2 (0.49) | ALDH1A1PTGS2MT-CO2NPSR1PKM | |
| SCHEMBL8477426 | 0.82 | PTGS2 (0.56) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 | |
| SCHEMBL1075895 | 0.81 | PTGS2 (0.54) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 | |
| SCHEMBL6820502 | 0.81 | PTGS2 (0.62) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 | |
| SCHEMBL3052006 | 0.81 | PTGS2 (0.54) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 | |
| SCHEMBL8911333 | 0.80 | ALDH1A1 (0.53) | ALDH1A1PTGS2MT-CO2NPSR1PKM | |
| SCHEMBL6990229 | 0.79 | PTGS2 (0.69) | ALDH1A1PTGS2MT-CO2NPSR1PKM | |
| SCHEMBL5071844 | 0.79 | PTGS2 (0.81) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 | |
| SCHEMBL8894627 | 0.77 | PTGS2 (0.55) | ALDH1A1PTGS2MT-CO2NPSR1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120165309-A1 | HETERO RING DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2397479-A1 | HETERO RING DERIVATIVE | Astellas Pharma Inc. (JP) | 2011-12-21 | — | — | EP | disclosed |
| WO-2010092962-A1 | HETERO RING DERIVATIVE | アステラス製薬株式会社 (JP) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165309-A1 | HETERO RING DERIVATIVE | IL2, PIK3R2, IL2RA | ALDH1A1 3496/4885PTGS2 137/4885MT-CO2 3942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.